Search For

Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity

Dysregulation of sphingolipid metabolism in liver fibrosis

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Is liver fibrosis a risk factor for gynecological cancers?

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Screening for advanced liver fibrosis in overweight and obese patients with NAFLD

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients